These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33283405)

  • 1. Gender effect on cardiac involvement in myotonic dystrophy type 1.
    Garibaldi M; Lauletta A; Bucci E; Fionda L; Vanoli F; Leonardi L; Alfieri G; Tufano L; Morino S; Merlonghi G; Anibaldi P; Salvetti M; Testa M; Antonini G
    Eur J Neurol; 2021 Apr; 28(4):1366-1374. PubMed ID: 33283405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.
    Bucci E; Testa M; Licchelli L; Frattari A; El Halabieh NA; Gabriele E; Pignatelli G; De Santis T; Fionda L; Vanoli F; Morino S; Garibaldi M; Di Pasquale A; Vanacore N; Botta A; Antonini G
    J Neurol; 2018 Apr; 265(4):885-895. PubMed ID: 29429070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
    Clarke NR; Kelion AD; Nixon J; Hilton-Jones D; Forfar JC
    Heart; 2001 Oct; 86(4):411-6. PubMed ID: 11559681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.
    Magrì D; Piccirillo G; Bucci E; Pignatelli G; Cauti FM; Morino S; Latino P; Santini D; Marrara F; Volpe M; Antonini G; Testa M
    Int J Cardiol; 2012 May; 156(3):259-64. PubMed ID: 21112106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
    Itoh H; Hisamatsu T; Tamura T; Segawa K; Takahashi T; Takada H; Kuru S; Wada C; Suzuki M; Suwazono S; Sasaki S; Okumura K; Horie M; Takahashi MP; Matumura T
    J Am Heart Assoc; 2020 Sep; 9(17):e015709. PubMed ID: 32812471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1.
    Scutifero M; Lanza M; Petillo R; De Bernardo M; Passamano L; Rosa N; Politano L
    Acta Myol; 2022; 41(3):105-110. PubMed ID: 36349183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Abnormalities in Congenital and Childhood Myotonic Muscular Dystrophy Type 1.
    Sharma A; Singh S; Mishra SK
    Neuropediatrics; 2017 Feb; 48(1):42-44. PubMed ID: 27992942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study.
    Petri H; Witting N; Ersbøll MK; Sajadieh A; Dunø M; Helweg-Larsen S; Vissing J; Køber L; Bundgaard H
    Int J Cardiol; 2014 Jun; 174(1):31-6. PubMed ID: 24704412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.
    Dogan C; De Antonio M; Hamroun D; Varet H; Fabbro M; Rougier F; Amarof K; Arne Bes MC; Bedat-Millet AL; Behin A; Bellance R; Bouhour F; Boutte C; Boyer F; Campana-Salort E; Chapon F; Cintas P; Desnuelle C; Deschamps R; Drouin-Garraud V; Ferrer X; Gervais-Bernard H; Ghorab K; Laforet P; Magot A; Magy L; Menard D; Minot MC; Nadaj-Pakleza A; Pellieux S; Pereon Y; Preudhomme M; Pouget J; Sacconi S; Sole G; Stojkovich T; Tiffreau V; Urtizberea A; Vial C; Zagnoli F; Caranhac G; Bourlier C; Riviere G; Geille A; Gherardi RK; Eymard B; Puymirat J; Katsahian S; Bassez G
    PLoS One; 2016; 11(2):e0148264. PubMed ID: 26849574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac manifestations of myotonic dystrophy type 1.
    Petri H; Vissing J; Witting N; Bundgaard H; Køber L
    Int J Cardiol; 2012 Oct; 160(2):82-8. PubMed ID: 21917328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive conduction disturbance in myotonic dystrophy.
    Palazzolo J; Trucco E; Arce M; Riera AR; Femenía F
    Cardiol J; 2011; 18(3):322-5. PubMed ID: 21660927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1.
    Groh WJ; Lowe MR; Simmons Z; Bhakta D; Pascuzzi RM
    Muscle Nerve; 2005 Jun; 31(6):719-24. PubMed ID: 15770673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length.
    Groh WJ; Lowe MR; Zipes DP
    J Cardiovasc Electrophysiol; 2002 May; 13(5):444-8. PubMed ID: 12030525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion.
    Tokgozoglu LS; Ashizawa T; Pacifico A; Armstrong RM; Epstein HF; Zoghbi WA
    JAMA; 1995 Sep; 274(10):813-9. PubMed ID: 7650805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
    Jean S; Richer L; Laberge L; Mathieu J
    Orphanet J Rare Dis; 2014 Nov; 9():186. PubMed ID: 25424323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables.
    Cudia P; Bernasconi P; Chiodelli R; Mangiola F; Bellocci F; Dello Russo A; Angelini C; Romeo V; Melacini P; Politano L; Palladino A; Nigro G; Siciliano G; Falorni M; Bongiorni MG; Falcone C; Mantegazza R; Morandi L
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):790-3. PubMed ID: 19237383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.